Under construction – not a live service
Sign in

2025-522348-42-00RecruitingPhase 1/2

Locating microclots with PET in post-COVID syndrome

LAMP-COVID: Locating Amyloid-containing Microclots with total-body PET in post-COVID syndrome

Source: EU CTIS (euclinicaltrials.eu) · Last updated 7 May 2026

Next steps

Brief summary (registry, in English)

To assess whether we are able to visualize and quantify a difference in amyloid containing microclots between post-COVID patients and controls using total-body dynamic [18F]flutemetamol PET.

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
65 (estimated)
First submitted
9 Feb 2026
Start date
5 Jul 2026
Lead sponsor
Amsterdam UMC Stichting
EU CT number
2025-522348-42-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 65
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • The subject is using anti-coagulant drugs.

Other illness

  • The subject has other medical conditions linked to amyloid-formation, such as diabetes, rheumatoid arthritis or neurodegenerative disorders.

Other

  • The subject is unable to undergo scanning procedures due to for example claustrophobia, severe back pain or trypanophobia (fear of needles).
  • The subject is a female of childbearing potential who is not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception.

Who the study is looking for

  • The subject was diagnosed with symptomatic COVID-19, confirmed by a positive PCR for SARS-CoV-2.
  • The subject is at least 12 months after being diagnosed with COVID-19.
  • The subject is in the range 40-65 years of age (to ensure radiation safety).
  • The subject has sufficient command of the Dutch language.
  • The subject is able to undergo the (PET) scanning procedures.

Age in the registry: 18 years to 64 years · Sex: All · Accepts healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Amsterdam UMC StichtingAmsterdamNetherlandsRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.